Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials.

Hauser SL, Bar-Or A, Giovannoni G, Montalban X, Lebrun-Frenay C, Amezcua L, Villar LM, Arnold DL, Weber MS, Filippi M, et al.